Benzinga | Jun 3, 2021 08:03AM EDT

Aethlon Medical Highlights Publication Of Case Studies Of Two Critically Ill COVID-19 Patients Treated With Hemopurifier

Aethlon Medical, Inc. (NASDAQ:AEMD), a medical device technology company focused on unmet needs in global health, today announced the publication of a pre-print manuscript highlighting two case studies of critically ill COVID-19 patients treated with the Aethlon Hemopurifier(r). Both patients were given access to Hemopurifier(r) treatment through Emergency Use. The manuscript is titled "Removal of COVID-19 Spike Protein, Whole Virus, Exosomes and Exosomal microRNAs by the Hemopurifier(r) Lectin-Affinity Cartridge in Critically Ill Patients with COVID-19 Infection" and was published in Research Square.